Pfizer Inc (PFE) stock
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3048% above fair value
$28.86−0.03 (-0.10%)
Close on Nov 16, 2026Market cap $164.49BP/E 38.0Yield 5.96%
Pfizer market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Pfizer's market cap was $167.84B on Nov 10, 2026, against $146.93B a year earlier. Over the last 5 years it ranged from $132.83B to $335.51B, with a median of $164.33B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $167.84B | +18.1% |
| 2025 | Dec 31, 2025 | $142.14B | -6.0% |
| 2024 | Dec 31, 2024 | $151.17B | -8.0% |
| 2023 | Dec 29, 2023 | $164.33B | -44.1% |
| 2022 | Dec 30, 2022 | $294.07B | -12.4% |
| 2021 | Dec 31, 2021 | $335.51B | +62.1% |
| 2020 | Dec 31, 2020 | $207.01B | -8.1% |
| 2019 | Dec 31, 2019 | $225.14B | -14.2% |
| 2018 | Dec 31, 2018 | $262.51B | +19.4% |
| 2017 | Dec 29, 2017 | $219.86B | +9.3% |
| 2016 | Dec 30, 2016 | $201.17B | -0.9% |
| 2015 | Dec 31, 2015 | $202.97B | +0.8% |
| 2014 | Dec 31, 2014 | $201.35B | -7.5% |
| 2013 | Dec 31, 2013 | $217.66B | +14.4% |
| 2012 | Dec 31, 2012 | $190.28B | +10.5% |
| 2011 | Dec 30, 2011 | $172.25B | +22.4% |
| 2010 | Dec 31, 2010 | $140.68B | +14.5% |
| 2009 | Dec 31, 2009 | $122.86B | – |
See a number that looks wrong?